NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:00 AM
23/07/2021 09:00
NASDAQ TRADE HALT CONTINUES CTKB.O REASON NOT AVAILABLE AT 04:00 AM
Recent news on Cytek Biosciences
See all newsCytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says (updated)
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says
Cytek Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cytek Biosciences Q2 revenue slightly misses estimates
Brief: Cytek Biosciences Q2 Revenue USD 48.14 Million